Yazmin I. Rovira Gonzalez, PhD, Johns Hopkins UniversityAlumna On May 18th 2020, Moderna, Inc. – a clinical-stage biotechnology company focused on mRNA technologies, including messenger RNA-based vaccines and therapies –…
Lawrence Jones, PhD- Johns Hopkins University Alumnus Universal vaccines may be a game changer for future infections. Researchers say a universal flu vaccine could be within reach sooner rather than…
Veta Obazenu, M.S. The World Health Organization (WHO) estimates that more than 1 billion people – one sixth of the world’s population — suffer from one or more neglected diseases….
by Tawney Hammet, M.S. Individualized Genomics & Health Candidate Johns Hopkins University Humanity is currently facing a new mortal enemy, SARS-CoV-2, or more commonly known as the virus that causes…
By: Yazmin I. Rovira Gonzalez, Ph.D. Johns Hopkins Alumna Sometime during my third year of graduate school, I started to realize that I needed to develop my professional skills in…
By Lawrence Jones, Ph.D. Johns Hopkins Alumnus In these times of the COVID-19 pandemic there is a race to find cures and vaccines throughout the world to get control of…
by Nate Hughes, MPP, MPH Johns Hopkins Alumnus Attracting upwards of 20,000 people in biotech, healthcare, venture capital and investment banking, the 38th annual J.P. Morgan Healthcare Conference took place…
John Jones, M.S. Biotechnology Johns Hopkins Alumnus Most articles found on social media that are contrarian to established science can be classified as science denial or misinformation. It is important…
by Roshan Chikarmane Ph.D. Candidate in Johns Hopkins School of Medicine Pharmacology & Molecular Sciences program Memories have a curious way of rising to the surface. Some memories are so…
By: Lawrence Jones, Ph.D. A newly published article February 4, 2020 in Advanced Functional Materials by brilliant engineers at Rutgers that used 4D printing to create tiny needles that mimic…
© 2020 Hopkins Biotech Network.